http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8140303-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20b3abeba6114f2270183ba2cc9fc3fd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-94 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate | 2008-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee10c05ae5a886d86619b55918b6515a |
| publicationDate | 2012-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-8140303-B2 |
| titleOfInvention | Bioequivalence evaluation method of evaluating bioequivalence of a generic drug to the corresponding original drug |
| abstract | [Problem] There is provided a bioequivalence evaluation method not only of evaluating bioequivalence between an original drug and a corresponding generic drug but also of enabling to compare bioequivalence between generic drugs. n [Means of Solving the Problem] The bioequivalence between generic drugs is evaluated according to the Expression (1) wherein CCV Cmax g stands for the calibration coefficient of variation of Cmax (the maximum blood concentration), CCV Tmax g stands for the calibration coefficient of variation of Tmax (the time to maximum blood concentration), CCV T1/2 g stands for the calibration coefficient of variation of the half-life (T 1/2 ), and CCV AUC g stands for the calibration coefficient of variation of AUC (the blood concentration-area under the curve). |
| priorityDate | 2008-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.